BRPI0415355A - triarilimidazóis - Google Patents

triarilimidazóis

Info

Publication number
BRPI0415355A
BRPI0415355A BRPI0415355-3A BRPI0415355A BRPI0415355A BR PI0415355 A BRPI0415355 A BR PI0415355A BR PI0415355 A BRPI0415355 A BR PI0415355A BR PI0415355 A BRPI0415355 A BR PI0415355A
Authority
BR
Brazil
Prior art keywords
triarylimidazoles
cancer
triarilimidazois
compounds
treatment
Prior art date
Application number
BRPI0415355-3A
Other languages
English (en)
Inventor
Thomas Von Hirschheydt
Edgar Voss
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0415355A publication Critical patent/BRPI0415355A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"TRIARILIMIDAZóIS". Compostos da fórmula geral (I) são terapêuticos valiosos para o tratamento de câncer e doenças relacionadas com o câncer.
BRPI0415355-3A 2003-10-16 2004-10-15 triarilimidazóis BRPI0415355A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03023633 2003-10-16
EP03026522 2003-11-18
PCT/EP2004/011600 WO2005040153A1 (en) 2003-10-16 2004-10-15 Novel triarylimidazoles

Publications (1)

Publication Number Publication Date
BRPI0415355A true BRPI0415355A (pt) 2006-12-12

Family

ID=34524706

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0415355-3A BRPI0415355A (pt) 2003-10-16 2004-10-15 triarilimidazóis

Country Status (12)

Country Link
US (1) US7144889B2 (pt)
EP (1) EP1675848A1 (pt)
JP (1) JP2007508345A (pt)
KR (1) KR100794948B1 (pt)
AR (1) AR046112A1 (pt)
AU (1) AU2004283846A1 (pt)
BR (1) BRPI0415355A (pt)
CA (1) CA2538131A1 (pt)
MX (1) MXPA06003699A (pt)
RU (1) RU2372346C2 (pt)
TW (1) TW200528444A (pt)
WO (1) WO2005040153A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007016286A1 (en) * 2005-07-28 2007-02-08 Janssen Pharmaceutica N.V. Synthesis of 4/5-pyrimidinylimidazoles via sequential functionalization of 2,4-dichloropyrimidine
EP2057164A1 (en) * 2006-08-07 2009-05-13 Incyte Corporation Triazolotriazines as kinase inhibitors
ES2555803T3 (es) 2006-10-23 2016-01-08 Cephalon, Inc. Fusión de derivados bicíclicos 2,4-diaminopirimidina como utilizar inhibidores ALK y c-Met
RS54510B1 (sr) 2006-11-22 2016-06-30 Incyte Holdings Corporation Imidazotriazini i imidazopirimidini kao inhibitori kinaze
US20110092452A1 (en) * 2008-03-05 2011-04-21 The Regents Of The University Of Michigan Compositions and methods for diagnosing and treating pancreatic cancer
TWI472529B (zh) 2008-05-21 2015-02-11 Incyte Corp ２－氟－Ｎ－甲基－４－〔７－（喹啉－６－基－甲基）－咪唑并〔１，２－ｂ〕〔１，２，４〕三－２－基〕苯甲醯胺之鹽類及其相關製備方法
MX2012008898A (es) 2010-02-03 2012-11-06 Incyte Corp Imidazo - [1, 2 - b] [1, 2, 4] triazinas como inhibidores de c - met.
WO2012084678A1 (en) 2010-12-23 2012-06-28 Syngenta Participations Ag Novel imidazoles useful as plant fungicides
MA52033A (fr) * 2014-08-13 2021-01-20 Nippon Soda Co Composé de diarylimidazole et agent de lutte antiparasitaire

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656644A (en) 1994-07-20 1997-08-12 Smithkline Beecham Corporation Pyridyl imidazoles
JPH10510281A (ja) 1994-12-13 1998-10-06 エフ・ホフマン−ラ ロシュ アーゲー イミダゾール誘導体
EP0994870A4 (en) 1997-06-19 2002-10-23 Smithkline Beecham NEW IMIDAZOLE COMPOUNDS SUBSTITUTED BY AN ARYLOXYREST
WO2001044154A1 (fr) 1999-12-17 2001-06-21 Mitsubishi Chemical Corporation Derives de dihalopropenyloxybenzene et pesticides contenant ces derniers en tant qu'ingredients actifs
US6790852B2 (en) 2002-04-18 2004-09-14 Hoffmann-La Roche Inc. 2-(2,6-dichlorophenyl)-diarylimidazoles

Also Published As

Publication number Publication date
AU2004283846A1 (en) 2005-05-06
RU2372346C2 (ru) 2009-11-10
RU2006116631A (ru) 2007-11-27
JP2007508345A (ja) 2007-04-05
KR20060056400A (ko) 2006-05-24
MXPA06003699A (es) 2006-06-05
TW200528444A (en) 2005-09-01
US7144889B2 (en) 2006-12-05
WO2005040153A1 (en) 2005-05-06
US20050085473A1 (en) 2005-04-21
AR046112A1 (es) 2005-11-23
KR100794948B1 (ko) 2008-01-15
EP1675848A1 (en) 2006-07-05
CA2538131A1 (en) 2005-05-06

Similar Documents

Publication Publication Date Title
MY135477A (en) 2-(2,6-dichlorophenyl)-diarylimidazoles
TW200509892A (en) Novel aminobenzophenone compounds
PH12013500123A1 (en) Hemiasterlin derivatives and uses thereof
SE0301700D0 (sv) Novel compounds
ATE442142T1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
SE0202539D0 (sv) Compounds
SE0200920D0 (sv) Novel compounds
ATE433447T1 (de) Pyrimiidinverbindungen
BRPI0415525A (pt) derivados de imidazola e seu uso como agentes farmacêuticos
BRPI0413449A (pt) compostos de quinoxalina
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
DE602004020070D1 (de) Thienopyrimidin-derivate als kaliumkanal-inhibitoren
UA83691C2 (ru) Применение замещенных 2-аминотетралинов для упреждающего лечения болезни паркинсона
SE0302139D0 (sv) Novel compounds
ATE409480T1 (de) Pyrazoloä3,4-büpyridin-6-one als gsk-3 inhibitoren
EA201170344A1 (ru) Азаиндольные ингибиторы iap
UA90698C2 (en) Triazole substituted aminobenzophenone compounds
WO2005030794A3 (en) Hemiasterlin derivatives and uses thereof
SE0003476D0 (sv) Compounds
BRPI0415355A (pt) triarilimidazóis
SE0303280D0 (sv) Novel compounds
SE0202693D0 (sv) Compounds
EA200600092A1 (ru) Новые цитотоксические депсипептиды
ATE423780T1 (de) Makrozyclen zur behandlung von krebserkrankungen
DK1618116T3 (da) Ruthenium(II)-komplekser til behandling af tumorer

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.